Inventor
TANIGUCHI MASARU
JP30 patents
⚠️ This page may combine multiple inventors who share the name “TANIGUCHI MASARU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIKEN
5 patentsUS11744860B2Sep 5, 2023
Technology for efficient activation of NKT cells
RIKEN0 citations52
US9493497B2Nov 15, 2016
Carbamate glycolipid and use thereof
RIKEN0 citations50
US9387170B2Jul 12, 2016
Drug having regulatory cell ligand contained in liposome
RIKEN0 citations49
US7928088B2Apr 19, 2011
Th1 cell differentiation accelerator
RIKEN0 citations49
US9464105B2Oct 11, 2016
Hydroxylated KRN7000 analogue and use thereof
RIKEN0 citations48
KENWOOD CORP
4 patentsUS7805294B2Sep 28, 2010
Wireless communication apparatus and wireless communication method
KENWOOD CORP7 citations73
US7738436B2Jun 15, 2010
Wireless communication system, wireless communication control apparatus, wireless communication apparatus and wireless communication method
KENWOOD CORP5 citations62
US7702033B2Apr 20, 2010
Modulating apparatus, mobile communication system, modulating method, and communication method
KENWOOD CORP1 citations52
US7826403B2Nov 2, 2010
Wireless communication control apparatus and wireless communication method to reduce inter-channel interference in narrow-band communications
KENWOOD CORP0 citations41
TASHIRO TAKUYA
4 patentsUS8551959B2Oct 8, 2013
Glycolipid and use thereof
TASHIRO TAKUYA2 citations59
US8299223B2Oct 30, 2012
Pseudoglycolipid and use thereof
TASHIRO TAKUYA4 citations59
US8163705B2Apr 24, 2012
Glycolipid and use thereof
TASHIRO TAKUYA3 citations56
US8853173B2Oct 7, 2014
Synthetic glycolipid and use thereof
TASHIRO TAKUYA1 citations49
TANIGUCHI MASARU
4 patentsUS8199854B2Jun 12, 2012
Modulating apparatus, mobile communication system, modulating method, and communication method
TANIGUCHI MASARU0 citations50
US8144809B2Mar 27, 2012
Modulating apparatus, mobile communication system, modulating method, and communication method
TANIGUCHI MASARU0 citations50
US10813950B2Oct 27, 2020
Immunotherapy using allo-NKT cells, cells for immunotherapy in which alpha chain of t-cell receptor (TCR) gene has been rearranged to uniform Vα-Jα, and banking of NKT cells derived from said cells
TANIGUCHI MASARU0 citations48
US9101558B2Aug 11, 2015
Use of anti-cancer cell composition for treatment of head and neck cancer, which is intended to be administered to nutrient artery of tumor
TANIGUCHI MASARU1 citations45
KIRIN BREWERY
2 patentsSMC CORP
2 patentsWATARAI HIROSHI
2 patentsUS8945922B2Feb 3, 2015
Generating a mature NKT cell from a reprogrammed somatic cell with a T-cell antigen receptor α-chain region rearranged to uniform Va-Ja in a NKT-cell specific way
WATARAI HIROSHI18 citations79
US8454955B2Jun 4, 2013
Methods for treating allergic airway inflammation, airway hypersensitivity, and eosinophilia
WATARAI HIROSHI0 citations49